About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in San Francisco | 5,215 Studies Near You

Clinical TrialsSan Francisco

Clinical Trials in San Francisco

Discover 5,215 clinical trials near San Francisco, California. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4041-4060 of 5,215 trials

RecruitingA Study of Psychedelics in Healthy Older Adults With Low Well-beingThis study is being conducted to understand changes in brain activity following administration of two different drugs (Psilocybin and Dextromethorphan) in older adults with low…NCT07386730·San Francisco, California Active not recruitingStudy of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)The Phase 2 study is a multicenter, open-label study of RP1 to further investigate safety and to estimate the efficacy of RP1 at the RP2D in combination with nivolumab in patients…NCT03767348·Birmingham, Alabama and 50 others

Find Trials by Condition in San Francisco

Breast Cancerin San Francisco Lung Cancerin San Francisco Prostate Cancerin San Francisco Colorectal Cancerin San Francisco Melanomain San Francisco Leukemiain San Francisco Lymphomain San Francisco Pancreatic Cancerin San Francisco Ovarian Cancerin San Francisco Brain Cancerin San Francisco

Data from ClinicalTrials.govTerms

CompletedA Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsThe purpose of the study is to evaluate the safety and to define the Maximal Tolerated Dose (MTD) or the Maximal Administered Dose (MAD) of oral azacitidine as a single agent and…NCT01478685·Scottsdale, Arizona and 12 others

CompletedIntegrative Approaches For Cancer Survivorship 2: Project 1The purpose of this study is to develop and test a 12-month Integrative Medicine intervention based on Ayurvedic medicine in recent breast cancer survivors.NCT02897635·San Francisco, California

RecruitingA Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload…NCT06926868·Hot Springs, Arkansas and 294 others

TerminatedCelecoxib in Treating Women With Metastatic or Recurrent Breast CancerRATIONALE: Celecoxib may stop the growth of tumor cells by blocking the enzymes necessary for their growth and by stopping blood flow to the tumor.NCT00045591·Anniston, Alabama and 73 others

CompletedLong-Term Outcome of Children and Adolescents With Anti-Phospholipid AntibodiesThis is a study about why some people have certain types of proteins in their blood, called anti-phospholipid antibodies.NCT00581763·San Francisco, California

CompletedCOHERE - COntextualized Care in cHcs' Electronic Health REcordsThis study was designed to develop and test clinical decision support (CDS) tools that present clinical care team members with a given patient's social risk information and…NCT05022316·San Francisco, California and 2 others

CompletedEcteinascidin 743 in Treating Adults With Advanced Solid TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002904·Vienna (Wien) and 48 others

CompletedA Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder CancerThis is a study that will test how an experimental drug (enfortumab vedotin) affects patients with cancer of the urinary system (urothelial cancer).NCT03219333·Anchorage, Alaska and 80 others

CompletedInfluence of OCTN2 Variants on Carnitine Status and Plasma TriglyceridesThe current study is part of a large multi-investigator grant to look at the pharmacogenetics of a number of membrane transporters.NCT00187733·San Francisco, California

CompletedPhase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell CarcinomaChemotherapy, radiation therapy, and surgery are standard treatments for basal cell carcinoma at most institutions.NCT01835626·San Francisco, California and 1 other

RecruitingLung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible SmokersChronic Obstructive Pulmonary Disease (COPD) is a heterogeneous disease that affects only a fraction of those who smoke tobacco.NCT04722835·San Francisco, California and 2 others

CompletedContinuous Versus Cyclical OCP Use in PCOSThe mainstay treatment for females with Polycystic Ovary Syndrome (PCOS) has long been a combination of an oral contraceptive pill or OCP (containing both estrogen and progestin)…NCT03819140·San Francisco, California

CompletedEffectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adherence in HIV Infected Men Released From PrisonThis study will evaluate the effectiveness of Structured Ecosystems Therapy (SET), a form of therapy that includes family and caregivers, at reducing HIV transmission risk…NCT00344591·San Francisco, California

Active not recruitingPersonalized DBS for OCD Guided by Stereoencephalography MappingThis is a double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open label stimulation for an additional 6 months.NCT06347978·San Francisco, California

Active not recruitingThe AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast CancerThis research study is studying a combination of drugs as a possible treatment for breast cancer.NCT03414658·Birmingham, Alabama and 16 others

CompletedA Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)The purpose of this study is to evaluate the safety and tolerability of long-term treatment with ontamalimab in participants with moderate to severe Ulcerative Colitis (UC) or…NCT03283085·Mesa, Arizona and 418 others

TerminatedA Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).Fibrodysplasia Ossificans Progressiva (FOP) is a rare, severely disabling disease characterized by the presence of bone in soft tissue where bone normally does not exist, known as…NCT05039515·San Francisco, California and 24 others

RecruitingClarifying the Optimal Application of SLT Therapy TrialThe goal of this study is to understand if SLT performed at low energy is as effective as SLT performed at standard energy, and also to see if repeating SLT at low energy once a…NCT04967989·Laguna Hills, California and 28 others

PreviousPage 203 of 261Next

Diabetes

in San Francisco

Heart Diseasein San Francisco